DQX1: A Drug Target / Disease Biomarker (G165545)

Target Name: DQX1

NCBI ID: G165545

DQX1

DQX1: A Drug Target / Disease Biomarker

DQX1, also known as IDH1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its role in various biological processes.

The DNA-binding domain (DBD) of DQX1 is a unique feature that gives it a distinct identity in the RNA universe. It consists of a nucleotide-binding oligomer that forms a base-pair with the first nucleotide of the target RNA. The DBD is responsible for the interaction between DQX1 and its target RNA, and is the site where most of the protein-coding genes are transcribed from RNA.

One of the most interesting aspects of DQX1 is its ability to interact with a wide range of RNA targets. Studies have shown that DQX1 can interact with genes that encode proteins involved in cell growth, apoptosis, and inflammation. This suggests that DQX1 may play a role in regulating these processes and may be a useful target for drugs that target these pathways.

Another key feature of DQX1 is its ability to form a complex with the protein encoded by the gene, IDH1. IDH1 is a gene that has been implicated in various diseases, including cancer. Its expression has been linked to poor prognosis in cancer patients, and targeting IDH1 has been shown to be a promising strategy for cancer treatment. The complex formation between DQX1 and IDH1 suggests that DQX1 may play a critical role in the regulation of IDH1 function and may be a useful biomarker for IDH1-positive tumors.

In addition to its potential as a drug target and biomarker, DQX1 has also been shown to have a wide range of functions in various biological processes. Studies have shown that DQX1 plays a role in regulating gene expression, DNA replication, and chromatin remodeling. It is also involved in cell adhesion, migration, and the regulation of cell cycle progression.

DQX1 has also been shown to play a role in the regulation of cellular processes that are important for human health and disease. For example, studies have shown that DQX1 is involved in the regulation of stem cell proliferation and that it plays a role in the development of cancer. Its expression has also been linked to various diseases, including heart disease, neurodegenerative diseases, and mental health conditions.

In conclusion, DQX1 is a non-coding RNA molecule that has a wide range of functions and has been shown to be involved in various biological processes that are important for human health and disease. Its unique structure and function make it an attractive target for researchers to study, and recent studies have shown that it has the potential to be a useful drug target and biomarker for a wide range of diseases. Further research is needed to fully understand the role of DQX1 in various biological processes and to develop effective treatments based on its unique properties.

Protein Name: DEAQ-box RNA Dependent ATPase 1

The "DQX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DQX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets